About VirIntel
VirIntel LLC is a diagnostic and research startup involved in a broad spectrum of projects concerning COVID-19. VirIntel immunology, bioinformatics and assay development experts have designed a dual-parameter serological test with 100% specificity, which allows to determine if a person’s immune system has created antibodies against the SARS-Cov-2.
Our other research projects involve broadening the scope of immune response analysis even further, exploring the antibody viral neutralization capabilities and vaccine design collaborations.
The VirIntel Mission
- To establish an agile and precise diagnostic testing platform within the area of virology and immunology, using the latest scientific, bioinformatics and collaboration approaches.
- To empower labs and physicians the ability to offer decisive diagnostics testing results to patients.
- To continue research on the most essential topics concerning the ongoing pandemic of COVID-19, including immune response analysis, viral neutralization studies, vaccine design and more.
